Literature DB >> 2370352

Neoplastic vs inflammatory meningeal enhancement with Gd-DTPA.

M E Phillips1, T J Ryals, S A Kambhu, W T Yuh.   

Abstract

We studied 40 consecutive patients clinically suspected of having meningeal disease, in whom both Gd-diethylenetriamine pentaacetic acid (DTPA)-enhanced magnetic resonance (MR) examinations and CSF or surgical pathologic samples were obtained. The MR examinations were retrospectively reviewed for the presence of abnormal meningeal enhancement, as well as pattern and site of enhancement. The MR findings correctly correlated with pathology results in 15 of 19 patients with suspected tumor involvement (including one true negative) and in 18 of 21 patients with suspected inflammatory meningeal conditions (including 2 true negatives). Pial enhancement was demonstrated in 62% (10 of 16) of patients with meningitis and in 29% (4 of 14) of patients with meningeal neoplastic involvement. A diffuse meningeal distribution was commonly present with inflammatory conditions (69%, 11 of 16). A nodular appearance was seen in two patients with tumor involvement of the meninges as well as in a single case of sarcoidosis but was not seen with infectious meningitis. Our data suggest that Gd-DTPA-enhanced MR imaging is sensitive to the presence of meningeal pathology but is nonspecific as to disease entity. Recognition of certain MR patterns in conjunction with clinical presentation may improve diagnosis and management of patients with suspected meningeal disease.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2370352     DOI: 10.1097/00004728-199007000-00007

Source DB:  PubMed          Journal:  J Comput Assist Tomogr        ISSN: 0363-8715            Impact factor:   1.826


  9 in total

Review 1.  Cerebral infections.

Authors:  Spyros Karampekios; John Hesselink
Journal:  Eur Radiol       Date:  2004-12-31       Impact factor: 5.315

Review 2.  Central nervous system disease in hematologic malignancies: historical perspective and practical applications.

Authors:  Ching-Hon Pui; Eckhard Thiel
Journal:  Semin Oncol       Date:  2009-08       Impact factor: 4.929

3.  Contrast-enhanced modified 3D T1-weighted TSE black-blood imaging can improve detection of infectious and neoplastic meningitis.

Authors:  Nora Navina Sommer; Romina Pons Lucas; Eva Coppenrath; Hendrik Kooijman; Franziska Galiè; Nina Hesse; Wieland H Sommer; Karla M Treitl; Tobias Saam; Matthias F Froelich
Journal:  Eur Radiol       Date:  2019-11-05       Impact factor: 5.315

4.  Incidence of and risk factors for involvement of the central nervous system in acute myeloid leukemia.

Authors:  Uri Rozovski; Maro Ohanian; Farhad Ravandi; Guillermo Garcia-Manero; Stefan Faderl; Sherry Pierce; Jorge Cortes; Zeev Estrov
Journal:  Leuk Lymphoma       Date:  2014-11-03

5.  Radiolabeled leucocyte imaging in diffuse granulomatous involvement of the meninges in Wegener's granulomatosis: scintigraphic findings and their role in monitoring treatment response to specific immunotherapy (humanized monoclonal antilymphocyte antibodies).

Authors:  J M Murphy; K K Balan; A Toms; B Gomez-Anson; M Lockwood
Journal:  AJNR Am J Neuroradiol       Date:  2000-09       Impact factor: 3.825

6.  Information value of magnetic resonance imaging in shunted hydrocephalus.

Authors:  E Pääkkö; T Löppönen; A L Saukkonen; J Pyhtinen; J Laitinen; W Serlo; M Knip
Journal:  Arch Dis Child       Date:  1994-06       Impact factor: 3.791

7.  Lesions of the central nervous system in leukemia: Pathological and magnetic resonance imaging features at presentation in 14 patients.

Authors:  Jing Liu; Yaming Wang; Xuefei Sun; Shuo Liu; Zhenkun Yu; Nan Ji; Shengjun Sun; Yuanbo Liu
Journal:  Oncol Lett       Date:  2017-10-16       Impact factor: 2.967

8.  Pictorial essay: Acute neurological complications in children with acute lymphoblastic leukemia.

Authors:  Seema A Kembhavi; Snehal Somvanshi; Shripad Banavali; Purna Kurkure; Brijesh Arora
Journal:  Indian J Radiol Imaging       Date:  2012-04

Review 9.  Extra-axial brain tumors.

Authors:  Antonios Drevelegas
Journal:  Eur Radiol       Date:  2004-12-31       Impact factor: 7.034

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.